Oaktree Capital Management’s Hims & Hers Health HIMS Stock Holding History

Oaktree Capital Management’s Portfolio HIMS Stock Details HIMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-666,962	Closed	-$12.3M	–	168
2024 Q3	$12.3M	Hold	666,962	–	–	0.2%	64
2024 Q2	$13.5M	Hold	666,962	–	–	0.21%	48
2024 Q1	$10.3M	Sell	666,962 -386,252	-37%	-$4.35M	0.16%	58
2023 Q4	$9.37M	Hold	1,053,214	–	–	0.14%	89
2023 Q3	$6.62M	Hold	1,053,214	–	–	0.1%	104
2023 Q2	$9.9M	Sell	1,053,214 -256,346	-20%	-$2.54M	0.13%	82
2023 Q1	$13M	Sell	1,309,560 -1,961,719	-60%	-$17.2M	0.14%	78
2022 Q4	$21M	Hold	3,271,279	–	–	0.22%	57
2022 Q3	$18.3M	Hold	3,271,279	–	–	0.2%	64
2022 Q2	$14.8M	Hold	3,271,279	–	–	0.17%	73
2022 Q1	$17.4M	Sell	3,271,279 -502,158	-13%	-$2.48M	0.18%	74
2021 Q4	$24.7M	Hold	3,773,437	–	–	0.27%	52
2021 Q3	$28.5M	Hold	3,773,437	–	–	0.4%	45
2021 Q2	$41.1M	Hold	3,773,437	–	–	0.55%	34
2021 Q1	$49.9M	Buy	+3,773,437	New	+$63.2M	0.69%	29

Other funds holding HIMS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Oaktree Capital Management's HIMS Position: Q4 2024 in Review

Oaktree Capital Management sold out of Hims & Hers Health (HIMS) in Q4 2024, closing a stake of 666,962 shares — an estimated $12.3M sold.

Oaktree Capital Management first reported a position in HIMS in Q1 2021 and held it in 15 quarters. The position peaked at $49.9M in Q1 2021. 394 funds tracked by Wall St. Rank hold HIMS as of Q4 2024.

Oaktree Capital Management reported no remaining Hims & Hers Health position as of Q4 2024 after selling out during the quarter.
Oaktree Capital Management sold 666,962 Hims & Hers Health shares in Q4 2024, an estimated $12.3M.
Oaktree Capital Management first reported a position in Hims & Hers Health in Q1 2021 and held it in 15 quarters.
Oaktree Capital Management's Hims & Hers Health position peaked at $49.9M in Q1 2021.
394 funds tracked by Wall St. Rank held Hims & Hers Health as of Q4 2024.

Based on Oaktree Capital Management's 13F filing for Q4 2024, filed 12 Feb 2025.